Draft Guidance for AI-Enabled Device Software Functions: Key Highlights
The FDA's draft guidance provides a comprehensive framework for the development, submission, and lifecycle management of AI-enabled device software functions (AI-DSFs). Aimed at industry and FDA staff, it emphasizes a Total Product Life Cycle (TPLC) approach to ensure safe, effective, and compliant AI-enabled medical devices.
Key Elements of the Guidance
Objective
The guidance aims to support industry compliance with FDA recommendations for AI-enabled devices, fostering innovation while prioritizing patient safety and device efficacy.
This document is a critical step toward creating a robust regulatory framework for AI in healthcare.
Source: https://www.fda.gov/media/184856/download
Region: United States of America
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert